Synaptics Incorporated filings document results reporting, governance changes, capital-structure actions and proxy disclosures for the semiconductor company. Form 8-K reports furnish quarterly and annual operating results, supplemental earnings materials and related GAAP and non-GAAP measures tied to revenue, margins, expenses and per-share results.
Other filings cover board-approved share repurchase authorization, amendments to bylaws, universal-proxy and advance-notice provisions, remote meeting mechanics, uncertificated shares and an exclusive-forum provision under Delaware corporate law. The definitive proxy statement documents shareholder voting matters, director elections, executive compensation, equity awards and pay-versus-performance disclosures.
SYNAPTICS Inc executive Vikram Gupta reported an open-market sale of 1,548 shares of Common Stock at $80.95 per share. The sale was made under a Rule 10b5-1 trading plan dated March 14, 2024, indicating it was pre-scheduled rather than opportunistic.
Separately, 5,518 shares were withheld by the company at $80.22 per share to cover tax obligations tied to restricted stock unit settlement, which is a non-market, mechanical disposition. After these transactions, Gupta directly holds 88,930 SYNAPTICS common shares, so the sale represents a small portion of his overall position.
SYNAPTICS Inc officer Ken Rizvi reported a tax-related share disposition. On settlement of restricted stock units, 5,895 shares of common stock were withheld by the company at $80.22 per share to cover tax withholding obligations, rather than sold on the open market.
After this tax-withholding event, Rizvi directly holds 111,984 shares of SYNAPTICS common stock, indicating he retains a substantial equity position following the restricted stock unit settlement.
The filing is a Form 144 notice related to proposed sales of common stock tied to restricted stock units. It lists 3,096 RSUs to be sold by an issuer transaction dated 04/17/2026. The filing also records two prior 10b5-1 sales of 772 shares each on 02/18/2026 and 02/25/2026, with reported proceeds of $65,620.00 and $62,972.04, respectively.
Morgan Stanley Smith Barney LLC submitted a Form 144 reporting proposed and completed dispositions of Common Stock tied to restricted stock units and 10b5-1 plans. The filing lists 1,798 Restricted Stock Units to be sold with an intended sale date of 04/17/2026. It also reports completed 10b5-1 sales of 334 shares on 03/18/2026 (proceeds $24,993.22) and 576 shares on 02/18/2026 (proceeds $48,919.68).
Synaptics Inc ownership update: The Vanguard Group filed Amendment No. 16 to a Schedule 13G/A reporting that, following an internal realignment, Vanguard and related subsidiaries will report holdings separately under SEC Release No. 34-39538. The filing states amount beneficially owned: 0 and percent of class: 0% as of the filing, and affirms holdings are 5% or less.
SYNAPTICS Inc officer Lisa Bodensteiner reported two transactions in company common stock. On March 18, 2026, she completed an open-market sale of 334 shares at $74.83 per share. After this sale, she directly held 71,191 shares of Synaptics stock.
On March 17, 2026, 782 shares were disposed of at $74.56 per share to satisfy tax withholding obligations tied to the settlement of restricted stock units, meaning these shares were withheld rather than sold for investment purposes. The filing notes that the sale was made under a Rule 10b5-1 trading plan dated September 9, 2025, indicating it was pre-planned.
Morgan Stanley Smith Barney LLC submitted a Form 144 disclosing a sale of 576 shares of common stock of SYNA by Lisa Bodensteiner on 02/18/2026 under a 10b5-1 plan for $48,919.68. The filing also lists 334 Restricted Stock Units with a 03/17/2026 date.
SYNAPTICS Inc officer Esther Song reported a routine tax-related share disposition. On the transaction date, 160 shares of common stock were withheld by the company at $74.56 per share to cover tax obligations from the settlement of restricted stock units. After this withholding, Song directly holds 21,280 shares of SYNAPTICS common stock.
SYNAPTICS Inc officer Satish Ganesan reported a small, routine tax-related share disposition. On this Form 4, 147 shares of common stock were withheld by the company at $74.56 per share to cover tax obligations tied to the settlement of restricted stock units. This was not an open-market sale, but an automatic tax-withholding mechanism. Following this transaction, Ganesan directly holds 76,677 shares of SYNAPTICS common stock.